![]() |
|
|
Vol. 300, Issue 2, 513-520, February 2002
Department of Oral and Craniofacial Biological Sciences, Dental
School, and Program in Neuroscience, University of Maryland,
Baltimore, Maryland
The role for excitatory amino acids (EAAs) in the rostral ventromedial
medulla (RVM) in descending pain modulation after persistent noxious
input is unclear. In an animal model of inflammatory hyperalgesia, we
examined the effects of intra-RVM microinjection of EAA receptor agonists and antagonists on paw withdrawal and tail-flick
responses in lightly anesthetized rats.
N-Methyl-D-aspartate (NMDA) produced effects
that depended upon the postinflammatory time period. At 3 h
postinflammation, NMDA induced facilitation at a lower dose (10 pmol)
and inhibition at a higher dose (1000 pmol). At 24 h postinflammation, NMDA (0.1-1000 pmol) produced a dose-dependent inhibition. The facilitation and inhibition, respectively, were attenuated significantly by the preadministration of an NMDA receptor antagonist, DL-2-amino-5-phosphonovaleric acid (APV) (10 pmol, P < 0.05), to the same site. Intra-RVM
microinjection of
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) (0.1-100 pmol) produced dose-dependent inhibition at both
3 and 24 h postinflammation that was blocked by the
preadministration of an AMPA/kainate receptor antagonist,
2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline (100 pmol, P < 0.05). Unexpectedly, AMPA-produced
inhibition was also significantly attenuated by preadministration of
APV (10 pmol, P < 0.05). Compared with 3 h
postinflammation, both NMDA and AMPA showed a leftward shift in their
dose-response curves at 24 h postinflammation. These results
demonstrate that NMDA and AMPA receptors in the RVM are involved in the
descending modulation after inflammatory hyperalgesia. There is a
time-dependent increase in EAA neurotransmission in the RVM after
inflammation and NMDA receptors play an important role in AMPA-produced inhibition.
This article has been cited by other articles:
![]() |
F. Wei, W. Guo, S. Zou, K. Ren, and R. Dubner Supraspinal Glial-Neuronal Interactions Contribute to Descending Pain Facilitation J. Neurosci., October 15, 2008; 28(42): 10482 - 10495. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Carlson, J. J. Maire, M. E. Martenson, and M. M. Heinricher Sensitization of Pain-Modulating Neurons in the Rostral Ventromedial Medulla after Peripheral Nerve Injury J. Neurosci., November 28, 2007; 27(48): 13222 - 13231. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Liu and J. M. Walker Effects of a Cannabinoid Agonist on Spinal Nociceptive Neurons in a Rodent Model of Neuropathic Pain J Neurophysiol, December 1, 2006; 96(6): 2984 - 2994. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, R. J. Traub, and A. Z. Murphy Persistent pain model reveals sex difference in morphine potency Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R300 - R306. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Guo, M. T. Robbins, F. Wei, S. Zou, R. Dubner, and K. Ren Supraspinal Brain-Derived Neurotrophic Factor Signaling: A Novel Mechanism for Descending Pain Facilitation J. Neurosci., January 4, 2006; 26(1): 126 - 137. [Abstract] [Full Text] [PDF] |
||||